Patients with indolent subtypes of NHL have a relatively good prognosis with a median survival as long as 20 years, although these subtypes of the disease are typically not curable in advanced stages.
Non-Hodgkin lymphoma (NHL) is far less predictable than Hodgkin lymphoma, and is more likely to spread to parts of the body outside of the lymphatic system.
Although it is very curable when found and treated early on, early-stage cervical cancer may not cause any noticeable signs or symptoms. In advanced stages, however, the disease may cause vaginal bleeding or discharge that is abnormal for the patient.1
Results 1 - 10 of 41